HAO Haoxi Health Technology Ltd
Fundamentals / CIK 0001954594 / USDHaoxi Health Technology Ltd reported $54.83M in revenue and a net loss of $9.54M for the fiscal year ended June 30, 2026 (up 67.1% year over year), with a 1.1% gross margin and a -17.6% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open HAO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2026$54.83M +67.1% YoY
-
Operating Income FY 2026-$9.66M -17.6% margin
-
Net Income FY 2026-$9.54M -17.4% net margin
-
Diluted EPS FY 2026-$386.40 Split-adjusted
-
Free Cash Flow FY 2026-- Operating CF less CapEx
-
Cash & ST Investments Jun 30, 2026$10.93M Total debt: $1.61M
Annual revenue and net income
5 fiscal years (2022 to 2026), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 |
|---|---|---|---|---|---|
| Revenue | $54.83M | $32.80M | $48.52M | $28.23M | $16.16M |
| Cost of Revenue | $54.20M | $31.88M | $45.77M | $26.17M | $15.51M |
| Gross Profit | $629K | $928K | $2.75M | $2.06M | $649K |
| Research & Development | $104K | $80K | $80K | $58K | $103K |
| Selling, General & Admin | $8.68M | $2.85M | $953K | $808K | $277K |
| Total Operating Expenses | $10.29M | $2.93M | $1.03M | $866K | $380K |
| Operating Income | -$9.66M | -$2.00M | $1.72M | $1.20M | $269K |
| EBITDA | -$9.36M | -$1.71M | $1.73M | $1.20M | $271K |
| Interest Income | $217K | $363K | $76K | -- | -- |
| Interest Expense | $52K | $46K | $41K | $20K | -- |
| Income Before Tax | -$9.50M | $4.15M | $1.74M | $1.19M | $260K |
| Income Tax Expense | $37K | $271K | $444K | $221K | $15K |
| Net Income | -$9.54M | $3.88M | $1.29M | $970K | $245K |
| Basic EPS | -$386.40 | $4,251.81 | $2,701.53 | $2,175.00 | $625.00 |
| Diluted EPS | -$386.40 | $3,385.53 | $2,701.53 | $2,175.00 | $625.00 |
| Basic Shares Outstanding | 24.7K | 912 | 478 | 442 | 400 |
| Diluted Shares Outstanding | 24.7K | 936 | 478 | 442 | 400 |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Jun 30 | Jun 30 | Jun 30 | Jun 30 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $10.93M | $8.62M | $6.66M | $1.20M |
| Cash & Short-Term Investments | $10.93M | $8.62M | $6.66M | $1.20M |
| Accounts Receivable, Net | $5.9K | $460K | $227K | $7.7K |
| Other Current Assets | $4.72M | $4.85M | $3.35M | -- |
| Total Current Assets | $16.81M | $19.60M | $15.38M | $3.67M |
| Property, Plant & Equipment, Net | $104K | $109K | $127K | $144K |
| Intangible Assets | -- | $1.80M | -- | -- |
| Total Non-Current Assets | $4.76M | $1.99M | $127K | $790K |
| Total Assets | $21.57M | $21.60M | $15.51M | $4.46M |
| Accounts Payable | $160K | $154K | $654K | $27K |
| Short-Term Debt | $1.61M | $1.61M | $834K | $539K |
| Deferred Revenue (Current) | $668K | $538K | $1.19M | -- |
| Total Current Liabilities | $3.71M | $3.91M | $3.87M | $2.58M |
| Long-Term Debt | -- | $307K | $302K | $249K |
| Other Non-Current Liabilities | -- | -- | $66K | $72K |
| Total Non-Current Liabilities | $0 | $307K | $368K | $321K |
| Total Liabilities | $3.71M | $4.22M | $4.23M | $2.90M |
| Total Debt (incl. Leases) | $1.61M | $1.99M | $1.14M | $877K |
| Retained Earnings | -$4.94M | $4.60M | $723K | -$568K |
| Accumulated Other Comp. Income | $83K | -$46K | -$44K | -$45K |
| Total Stockholders' Equity | $17.86M | $17.38M | $11.27M | $1.57M |
| Total Equity | $17.86M | $17.38M | $11.27M | $1.57M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $10.93M | $8.62M | $6.66M | $1.20M |
| Cash & Short-Term Investments | $10.93M | $8.62M | $6.66M | $1.20M |
| Accounts Receivable, Net | $5.9K | $460K | $227K | $7.7K |
| Other Current Assets | $4.72M | $4.85M | $3.35M | -- |
| Total Current Assets | $16.81M | $19.60M | $15.38M | $3.67M |
| Property, Plant & Equipment, Net | $104K | $109K | $127K | $144K |
| Intangible Assets | -- | $1.80M | -- | -- |
| Total Non-Current Assets | $4.76M | $1.99M | $127K | $790K |
| Total Assets | $21.57M | $21.60M | $15.51M | $4.46M |
| Accounts Payable | $160K | $154K | $654K | $27K |
| Short-Term Debt | $1.61M | $1.61M | $834K | $539K |
| Deferred Revenue (Current) | $668K | $538K | $1.19M | -- |
| Total Current Liabilities | $3.71M | $3.91M | $3.87M | $2.58M |
| Long-Term Debt | -- | $307K | $302K | $249K |
| Other Non-Current Liabilities | -- | -- | $66K | $72K |
| Total Non-Current Liabilities | $0 | $307K | $368K | $321K |
| Total Liabilities | $3.71M | $4.22M | $4.23M | $2.90M |
| Total Debt (incl. Leases) | $1.61M | $1.99M | $1.14M | $877K |
| Retained Earnings | -$4.94M | $4.60M | $723K | -$568K |
| Accumulated Other Comp. Income | $83K | -$46K | -$44K | -$45K |
| Total Stockholders' Equity | $17.86M | $17.38M | $11.27M | $1.57M |
| Total Equity | $17.86M | $17.38M | $11.27M | $1.57M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 |
|---|---|---|---|---|---|
| Net Income | -$9.54M | $3.88M | $1.29M | $970K | $245K |
| Depreciation & Amortization | $309K | $295K | $11K | $8.4K | $2.2K |
| Stock-Based Compensation | -- | $59K | -- | -- | -- |
| Change in Receivables | $440K | -$254K | -$218K | -$4.3K | $666K |
| Change in Payables | -$1.6K | -$497K | $623K | -$1.20M | -$1.60M |
| Operating Cash Flow | -$2.57M | -$3.36M | -$748K | -$872K | -$675K |
| Capital Expenditure | -- | -- | -$55K | -$46K | -$8.7K |
| Free Cash Flow | -- | -- | -$803K | -$918K | -$684K |
| Purchases of Investments | -$4.50M | -- | -- | -- | -- |
| Investing Cash Flow | -$4.50M | -$3.58M | -$3.13M | -$46K | -$8.7K |
| Common Stock Issued | -- | -- | $8.98M | $1.99M | $164K |
| Financing Cash Flow | $9.33M | $8.90M | $9.32M | $1.80M | $933K |
| Net Change in Cash | $2.31M | $1.96M | $5.45M | $910K | $238K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 |
|---|---|---|---|---|---|
| Gross Margin | 1.1% | 2.8% | 5.7% | 7.3% | 4.0% |
| Operating Margin | -17.6% | -6.1% | 3.5% | 4.2% | 1.7% |
| Net Profit Margin | -17.4% | 11.8% | 2.7% | 3.4% | 1.5% |
| Return on Equity (ROE) | -53.4% | 22.3% | 11.5% | 61.9% | -- |
| Return on Assets (ROA) | -44.2% | 18.0% | 8.3% | 21.7% | -- |
| Current Ratio | 4.53x | 5.01x | 3.98x | 1.43x | -- |
| Quick Ratio | 2.95x | 2.32x | 1.78x | 0.47x | -- |
| Debt to Equity | 0.09x | 0.11x | 0.10x | 0.56x | -- |
| Revenue Growth (YoY) | +67.1% | -32.4% | +71.9% | +74.7% | -- |
| Gross Profit Growth (YoY) | -32.2% | -66.3% | +33.4% | +217.9% | -- |
| Operating Income Growth (YoY) | -- | -216.5% | +43.6% | +344.9% | -- |
| Net Income Growth (YoY) | -346.0% | +200.1% | +33.2% | +296.5% | -- |
| EPS Growth (YoY) | -109.1% | +57.4% | +24.2% | +248.0% | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.